[Gastrointestinal stromal tumor: epidemiology and outcome study in 40 cases]
Tunisie Medicale [La]. 2006; 84 (1): 26-29
in French
| IMEMR
| ID: emr-81415
ABSTRACT
The aim of this study was to analyze epidemiology and outcome of 40 patients with gastrointestinal stromal tumor [GIST] expressed CD117. All epidemiological data [age, sex, location] and survival data were analyzed retrospectively. The tumors occurred in 17 men and 23 women. Stomach was the most common site of localization [47.5%]. Of the 37 patients without Gleevec treatment, 18 benign cases [66.6%] showed long-term survival [2 to 8 years] and 9 malignant cases [33.3%] were diagnosed. 10 cases were still being in followed [< 2 years]. Gastric tumor's survival was better than extragastric tumor's survival without statistically significance [p>0.05]. Our experience confirms that GIST is an aggressive tumor. 33.33% of them are malignant with recurrence or metastatic potential. Additionally, epidemiologic factors [age, sex and location] do not have a predictive value
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Epidemiology
/
Treatment Outcome
Type of study:
Screening study
Limits:
Female
/
Humans
/
Male
Language:
French
Journal:
Tunisie Med.
Year:
2006
Similar
MEDLINE
...
LILACS
LIS